Addition of pentoxifylline to pegylated interferon-alpha-2a and ribavirin improves sustained virological response to chronic hepatitis C virus: a randomized clinical trial
Journal Title: Annals of Hepatology - Year 2013, Vol 12, Issue 2
Abstract
[b]Background and aim.[/b] The commonly accepted treatment for hepatitis C virus (HCV) infection, pegylated interferon alpha (PEG INF-alpha) and ribavirin, leads to 50-60% of sustained virological response (SVR). On the other hand, pentoxifylline (PTX) possesses antiviral and hepatoprotector properties. [b]Aim[/b]. To investigate whether the addition of PTX to conventional hepatitis C treatment increases SVR. [b]Material and methods. [/b]Seventy two patients of both genders were studied in a randomized fashion; the diagnosis of chronic HCV infection was made according to clinical and laboratory criteria and histopathologically classified according to METAVIR scoring system criteria. HCV viral load was tested by PCR, baseline, and after 6 months of treatment, as well as anti-HCV, anti-hepatitis B virus , and anti-human immunodeficiency virus antibodies by enzyme-linked immunosorbent assay. During 48 weeks, control group patients were treated with PEG INFalpha- 2a plus ribavirin. PTX was administered to Experimental Group patients prior to the treatment. [b]Results[/b]. Demographic data were similar in both groups. Experimental- and control-group subjects were at F2 and F3 states according to the METAVIR classification. The most common HCV genotypes were 1a and 1b (39% in the control group in each case, and 42% in the experimental group in each case). At the end of the study, hepatic enzymes and viral load decreased in both groups to similar values. SVR in the experimental group increased significantly (p < 0.05) when compared with standard therapy alone. [b]Conclusion[/b]. Addition of PTX to conventional chronic hepatitis C treatment may increase the percentage of patients with SVR.
Authors and Affiliations
Miguel Jiménez-Luévano, José Lerma-Díaz, Georgina Hernández-Flores, Alejandro Bravo-Cuellar
Keywords
Related Articles
- EP ID EP78258
- DOI -
- Views 132
- Downloads 0
Burden of Chronic Viral Hepatitis and Liver Cirrhosis in Brazil - the Brazilian Global Burden of Disease Study
Introduction and aim. Data on epidemiology of liver diseases in Brazil is scarce. This study aimed to estimate the burden of chronic viral hepatitis and liver cirrhosis in the country. Materials and methods.The indicator...
Chemerin, retinol binding protein-4, cytokeratin-18 and transgelin-2 presence in sera of patients with non-alcoholic liver fatty disease
Background. Chemerin and retinol binding protein-4 (RBP-4) are adipokines which may play a role in the progression of NAFLD. Ithas been also suggested that cytokeratin-18 (CK-18) could be a marker of hepatocyte caspase-...
Annals Impact Factor 1.67. Welcome to the IF club: achievement and challeng
Biliverdin and Heme Oxygenase Antiviral Activity Against Hepatitis C Virus
Percutaneous liver biopsy – 2 decades of experience in a public hospital in the South of Brazil
Introduction. Liver biopsy is a complementary method for diagnosis, staging and therapeutic guidance in liver diseases, where chronic viral hepatitis are the most acknowledged causes for the indication of histopathologic...